A functional genomics approach to identify pathways of drug resistance in medulloblastoma

Acta Neuropathol Commun. 2018 Dec 27;6(1):146. doi: 10.1186/s40478-018-0652-8.
No abstract available

Keywords: Brain tumor; Cancer; Drug resistance; Functional genomics; Medulloblastoma; Sleeping beauty; Transposon mutagenesis.

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anilides / adverse effects
  • Animals
  • Cerebellar Neoplasms / drug therapy
  • Cerebellar Neoplasms / genetics*
  • Cerebellar Neoplasms / mortality
  • Disease Models, Animal
  • Drug Delivery Systems
  • Drug Resistance, Neoplasm / genetics*
  • Gene Regulatory Networks
  • Genomics / methods*
  • Humans
  • Medulloblastoma / drug therapy
  • Medulloblastoma / genetics*
  • Medulloblastoma / mortality
  • Mice
  • Mice, Transgenic
  • Mutation / genetics
  • Patched-1 Receptor / genetics
  • Patched-1 Receptor / metabolism
  • Quinolines / adverse effects
  • Signal Transduction / genetics*
  • Transposases / genetics*

Substances

  • Anilides
  • GSK 1363089
  • PTCH1 protein, human
  • Patched-1 Receptor
  • Quinolines
  • Transposases
  • sleeping beauty transposase, human